Shield Therapeutics plc (FRA:1JS)

Shield Therapeutics Revenue

Shield Therapeutics had revenue of $21.45M USD in the half year ending June 30, 2025, with 472.99% growth. This brings the company's revenue in the last twelve months to $41.50M, up 93.23% year-over-year. In the year 2024, Shield Therapeutics had annual revenue of $32.18M with 145.93% growth.

• Revenue (ttm): $41.50M
• Revenue Growth: +93.23%
• P/S Ratio: 3.32
• Revenue / Employee: $658.65K
• Employees: 63
• Market Cap: 117.16M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.18M	19.10M	145.93%
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.44M	167.35%
Dec 31, 2021	2.06M	-12.12M	-85.50%
Dec 31, 2020	14.18M	13.23M	1,389.24%